Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
c-117 (1 trial)
Intracranial Arteriosclerosis (Phase 2)
Intracranial Embolism (Phase 2)
Intracranial Thrombosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)